Brokerages Set Mobia Medical, Inc. (NASDAQ:MOBI) PT at $20.25

Mobia Medical, Inc. (NASDAQ:MOBI) has been given a consensus rating of “Moderate Buy” by the six brokerages that are presently covering the company, MarketBeat Ratings reports. One equities research analyst has rated the stock with a hold recommendation and five have issued a buy recommendation on the company. The average twelve-month target price among analysts that have issued a report on the stock in the last year is $20.25.

MOBI has been the subject of a number of analyst reports. Bank of America started coverage on Mobia Medical in a report on Tuesday, June 2nd. They set a “buy” rating and a $16.00 target price for the company. Wolfe Research started coverage on Mobia Medical in a report on Tuesday, June 2nd. They issued an “outperform” rating on the stock. JPMorgan Chase & Co. started coverage on Mobia Medical in a research report on Tuesday, June 2nd. They issued an “overweight” rating and a $15.00 price target for the company. The Goldman Sachs Group began coverage on Mobia Medical in a research note on Tuesday, June 2nd. They set a “buy” rating and a $31.00 price objective for the company. Finally, Wall Street Zen raised Mobia Medical from a “sell” rating to a “hold” rating in a research report on Sunday, June 14th.

Insider Buying and Selling at Mobia Medical

In other news, Director Dana G. Jr. Mead purchased 7,000 shares of the firm’s stock in a transaction on Monday, May 11th. The stock was acquired at an average cost of $15.00 per share, with a total value of $105,000.00. Following the completion of the transaction, the director owned 7,000 shares in the company, valued at $105,000. This represents a ∞ increase in their position. The purchase was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, Director Cynthia L. Lucchese acquired 125,000 shares of the business’s stock in a transaction dated Monday, May 11th. The stock was purchased at an average cost of $15.00 per share, for a total transaction of $1,875,000.00. Following the transaction, the director owned 125,000 shares in the company, valued at approximately $1,875,000. The trade was a ∞ increase in their ownership of the stock. The SEC filing for this purchase provides additional information. In the last quarter, insiders bought 1,273,332 shares of company stock valued at $19,088,930.

Mobia Medical Price Performance

Shares of MOBI opened at $13.65 on Friday. Mobia Medical has a fifty-two week low of $10.19 and a fifty-two week high of $15.29. The company has a market capitalization of $453.85 million, a PE ratio of -0.71 and a beta of 2.84.

Mobia Medical (NASDAQ:MOBI) last released its quarterly earnings data on Thursday, June 4th. The company reported ($19.30) earnings per share (EPS) for the quarter. The firm had revenue of $12.07 million for the quarter.